Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease

Injectable sponge-like gel enhances the quantity and quality of T-cells

New advances selectively suppress damaged cells, allowing for transplants without chemotherapy or radiation

New protocol produces large numbers of mature human podocytes, enabling kidney disease modeling, drug discovery, and potential cell therapies